Table 1 Baseline clinical and MRI characteristics of patients with severe aortic stenosis

ALL (n=11)

LGE positive (n=6)

LGE negative (n=5)

P - value

AGE, years +/- SD

66.2 ± 10.7

67.1 ± 12.4

65.2 ± 9.4

0.77

Male, n (%)

9 (81.8)

5 (83.3)

4 (80)

0.88

DM, n (%)

4 (36.4)

3 (50)

1 (20)

0.30

Hypertension, n (%)

10 (90.9)

5 (83.3)

5 (100)

0.33

DLP, n (%)

6 (54.5)

3 (50)

3 (60)

0.74

AFib, n (%)

3 (27.3)

1 (16.6)

2 (40)

0.38

CAD, n (%)

3 (27.8)

3 (50)

0 (0)

0.06

ACEI, n (%)

9 (81.8)

4 (66.7)

5 (100)

0.15

BBlock, n (%)

9 (81.8)

4 (66.7)

5 (100)

0.15

Labs

Cr, ± SD

1.22 ± 0.26

1.31 ± 0.11

1.12 ± 0.09

0.24

Ht, ± SD

42.63 ± 3.61

40.6 ±2.7

44.3 ± 3.5

0.08

MRI

LVEDVI, ml/m2 ± SD

139.8 ± 52.1

124.8 ± 52.2

157.8 ± 51.3

0.32

LVEF,% ± SD

28.7 ± 11.2

33.5 ± 8.9

23 ± 11.8

0.12

RVEDVI, ml/m2 ± SD

66.1 ± 30.9

52 ± 15.5

83.2 ± 37.8

0.06

RVEF, ml/m2 ± SD

41 ± 17.0

30.6 ± 15.0

49.6 ± 14.1

0.06

LV mass, g ± SD

212.2 ± 46.4

199.5 ± 38.1

227.4 ± 55.0

0.34

Valve area, cm2 ± SD

0.64 ± 0.27

0.68 ± 0.3

0.59 ± 0.24

0.59

Fibrosis, g± SD

11.5 ± 16.4

21.1 ± 17.1

0

0.02

Fibrosis, % ± SD

6.2 ± 9.0

11.3 ± 9.7

0

0.03

T1 native, ms ± SD

1008.6 ± 125.3

1023.3 ± 102.5

991 ± 159.3

0.69

T1 post, ms ± SD

439.9 ± 111.3

473.6 ± 54.7

399.4 ± 30.7

0.29

ECV, % ± SD

31.6 ± 5.5

32.9 ± 2.3

29.8 ± 2.4

0.38

ECV remote, % ± SD

30.2 ± 5.9

30.7 ± 4.5

30.0 ± 8.0

0.84